Filtered By:
Source: BMC Neurology
Condition: Thrombosis
This page shows you your search results in order of date. This is page number 3.
Order by Relevance | Date
Total 32 results found since Jan 2013.
Rate of deep-vein thrombosis and pulmonary embolism during the care continuum in patients with acute ischemic stroke in the United States
Conclusions:
Approximately 1% of patients with AIS experienced symptomatic in-hospital and/or post-discharge DVT/PE. Although 46% received prophylaxis in-hospital, only 6% received prophylaxis in the outpatient setting. This highlights the need for sustained thromboprophylaxis prescribing across the continuum of care.
Source: BMC Neurology - February 8, 2013 Category: Neurology Authors: Alpesh AminJay LinStephen ThompsonDaniel Wiederkehr Source Type: research
Thromboembolic risks of recombinant factor VIIa Use in warfarin-associated intracranial hemorrhage: a case¿control study
Background:
Recombinant factor VIIa (rFVIIa) may be used for rapid hemostasis in life-threatening hemorrhage. In warfarin-associated intracerebral hemorrhage (wICH), FVIIa use is controversial and may carry significant thromboembolic risks. We compared incidence of baseline thromboembolic risk factors and thromboembolism rates in wICH patients treated with additional rFVIIa to those treated with standard therapy of fresh frozen plasma (FFP) and vitamin K alone.
Methods:
We identified 45 consecutive wICH patients treated with additional rFVIIa over 5-year period, and 34 consecutive wICH patients treated with standard therap...
Source: BMC Neurology - December 15, 2012 Category: Neurology Authors: Chou H-YCai XuemeiKonigsberg GBresette MHenderson VSorond AFeske K Source Type: research
